Cancer Detection and Therapy Research Program shared on LinkedIn:
”Congratulations to Sam Humphries, who has received funding through the 2026 Cancer Detection and Therapy Research Program HMRI EMCR Pilot Funding Scheme!
This scheme supports emerging researchers within the CDT Program to develop their research capacity, generate preliminary data and advance innovative projects with the potential to improve cancer detection, treatment and patient outcomes.
Project title: Targeting Glioblastoma using Advanced 3D Tumour Models
About the project:
Glioblastoma (GBM) is the most common and aggressive form of malignant brain tumour in adults, with current therapies only providing a median survival of around 15 months, and 5-year survival below 10%. Emerging evidence indicates that GBM cells exploit specific growth factor signalling pathways to promote survival and treatment resistance. This project aims to determine whether inhibition of growth factor signalling can enhance the effectiveness of standard therapy in GBM and reduce the risk for disease recurrence. This would lead the way to a first targeted therapy in GBM.
Congratulations to Sam – we look forward to following the progress of this exciting research!”
To which, Mark Hughes Foundation Centre for Brain Cancer Research, added:
”Congratulations Sam, great to see you receive funding for this important work. Bravo!”
You can also read: ‘Archie Goodburn: Defying Oligodendroglioma While Racing for the Future of Brain Cancer Care‘
